PacWest Financial Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$21M Buy
68,281
+2,647
+4% +$80.8K 1.25% 32
2016
Q3
$2.11M Buy
65,634
+1,128
+2% +$37.7K 1.29% 29
2016
Q2
$2.15M Sell
64,506
-3,170
-5% -$101K 1.35% 24
2016
Q1
$1.9M Sell
67,676
-982
-1% -$28.1K 1.23% 33
2015
Q4
$2.1M Buy
68,658
+3,068
+5% +$96.5K 1.41% 24
2015
Q3
$1.96M Buy
65,590
+601
+0.9% +$19.3K 1.45% 23
2015
Q2
$2.07M Sell
64,989
-189
-0.3% -$6.16K 1.46% 22
2015
Q1
$2.15M Buy
65,178
+579
+0.9% +$18.4K 1.52% 19
2014
Q4
$1.91M Sell
64,599
-59
-0.1% -$1.69K 1.35% 27
2014
Q3
$1.81M Buy
64,658
+722
+1% +$20.3K 1.35% 27
2014
Q2
$1.8M Buy
63,936
+5,350
+9% +$153K 1.34% 26
2014
Q1
$1.78M Buy
58,586
+7,178
+14% +$214K 1.38% 24
2013
Q4
$1.49K Sell
51,408
-637
-1% -$18.5K 0.45% 35
2013
Q3
$1.42M Sell
52,045
-517
-1% -$14.1K 1.22% 33
2013
Q2
$1.4M Buy
+52,562
New +$1.45M 1.33% 28

Other funds holding PFE

PacWest Financial Management's PFE Position: Q4 2016 in Review

PacWest Financial Management increased its Pfizer (PFE) stake by 4% in Q4 2016, buying an estimated $80.8K and bringing the position to 68,281 shares worth $21M. The position accounts for 1.25% of the portfolio, ranked #32.

PacWest Financial Management first reported a position in PFE in Q2 2013 and has held it in 15 quarters since. 2,060 funds tracked by Wall St. Rank hold PFE as of Q4 2016.

  • PacWest Financial Management held 68,281 shares of Pfizer worth $21M as of Q4 2016.
  • PacWest Financial Management bought 2,647 Pfizer shares in Q4 2016, an estimated $80.8K.
  • Pfizer made up 1.25% of PacWest Financial Management's portfolio in Q4 2016, its #32 holding.
  • PacWest Financial Management first reported a position in Pfizer in Q2 2013 and has held it in 15 quarters since.
  • 2,060 funds tracked by Wall St. Rank held Pfizer as of Q4 2016.

Based on PacWest Financial Management's 13F filing for Q4 2016, filed 10 Jan 2017.